scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1032310618 |
P356 | DOI | 10.1186/S41182-016-0024-7 |
P932 | PMC publication ID | 4989295 |
P698 | PubMed publication ID | 27579019 |
P2093 | author name string | Nobuo Ohta | |
Rieko Shimogawara | |||
Ki-Ichi Yamamoto | |||
Ripa Jamal | |||
P2860 | cites work | Epidemic influenza and vitamin D | Q24617494 |
The vitamin D-antimicrobial peptide pathway and its role in protection against infection | Q24647840 | ||
Tsetse Flies (Glossina) as Vectors of Human African Trypanosomiasis: A Review | Q26748948 | ||
New developments and novel therapeutic perspectives for vitamin C | Q28250002 | ||
Exploring the Trypanosoma brucei Hsp83 potential as a target for structure guided drug design | Q28534499 | ||
Evidence that vitamin D(3) promotes mast cell-dependent reduction of chronic UVB-induced skin pathology in mice | Q33730140 | ||
Vitamin D and the intracrinology of innate immunity | Q33787809 | ||
Prospects for control of African trypanosomiasis by tsetse vector manipulation | Q33929923 | ||
Vitamin D inhibits the occurrence of experimental cerebral malaria in mice by suppressing the host inflammatory response | Q33948630 | ||
Vitamin D: modulator of the immune system. | Q34112707 | ||
Drug resistance in pathogenic African trypanosomes: what hopes for the future? | Q34169602 | ||
1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes | Q34624558 | ||
Co-enzyme Q10 and idebenone use in Friedreich's ataxia | Q34654338 | ||
Novel antitrypanosomal agents | Q36210891 | ||
Inhibition of the infectivity of influenza virus by tea polyphenols | Q36753216 | ||
How to calculate sample size in animal studies? | Q37303624 | ||
Vitamin D3: a helpful immuno-modulator | Q37927252 | ||
Curcumin nanoformulations: a future nanomedicine for cancer | Q37940793 | ||
Innovative lead compounds and formulation strategies as newer kinetoplastid therapies. | Q38029744 | ||
A Host-Pathogen Interaction Reduced to First Principles: Antigenic Variation in T. brucei | Q38625365 | ||
Mapping the economic benefits to livestock keepers from intervening against bovine trypanosomosis in Eastern Africa | Q38863981 | ||
Defective neutrophil motility in hypovitaminosis D rickets | Q40029937 | ||
EFFECTS OF VITAMIN C SUPPLEMENTATION ON THE CHRONIC PHASE OF CHAGAS DISEASE. | Q41095664 | ||
The beneficial effect of dietary zinc supplementation on anaemia and immunosuppression in Trypanosoma brucei infected rats | Q41285583 | ||
Antitrypanosomal agents: treatment or threat? | Q42917874 | ||
Development of an Alamar Blue viability assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427. | Q43264845 | ||
Some biochemical changes following Trypanosoma congolense infection in Djallonké ewe lambs and breeding ewes fed on two levels of nutrition | Q43442738 | ||
Nonnatural amino acid ligands in heme protein design. | Q44024068 | ||
Stabilization of collagen using plant polyphenol: role of catechin | Q46719887 | ||
Comparative histopathology of the lymph nodes, spleen, liver and kidney in experimental ovine trypanosomosis | Q46953399 | ||
Classical CD11c+ dendritic cells, not plasmacytoid dendritic cells, induce T cell responses to Plasmodium chabaudi malaria | Q47921593 | ||
Acute neurocognitive effects of epigallocatechin gallate (EGCG). | Q50506881 | ||
Different types of tea products attenuate inflammation induced in Trypanosoma brucei infected mice. | Q50636108 | ||
Prospects for control of African trypanosomiasis by tsetse vector manipulation | Q57024060 | ||
Vitamin D overload and experimental Trypanosoma cruzi infection: Parasitological and histopathological aspects | Q58227674 | ||
Trypanosoma cruzi: in vitro and in vivo antiproliferative effects of epigallocatechin gallate (EGCg) | Q58844846 | ||
Continuous growth of bloodstream forms of Trypanosoma brucei brucei in an axenic culture system containing a low concentration of serum | Q78100324 | ||
P921 | main subject | Trypanosoma brucei | Q33244 |
vitamin | Q34956 | ||
cholecalciferol | Q139347 | ||
vitamin D | Q175621 | ||
P304 | page(s) | 26 | |
P577 | publication date | 2016-08-08 | |
P1433 | published in | Tropical Medicine and Health | Q6158243 |
P1476 | title | Anti-trypanosome effects of nutritional supplements and vitamin D3: in vitro and in vivo efficacy against Trypanosoma brucei brucei | |
P478 | volume | 44 |
Q59798766 | Host-Directed Drug Therapies for Neglected Tropical Diseases Caused by Protozoan Parasites | cites work | P2860 |
Search more.